Gate Neurosciences retweeted
.@GateNeuro and @biosignals illuminate depression biomarkers with EEG bioworld.com/articles/705051 #biotech #pharma
Gate Neurosciences retweeted
Excited to partner with @GateNeuro for a Phase 2 trial on zelquistinel to treat major depressive disorder! 🚀 Leveraging FDA-cleared Dreem 3S headband & our AI Analytics, we're bringing precision to psychiatry with novel EEG biomarkers and sleep endpoints!
businesswire.com/news/home/2…
Gate Neurosciences retweeted
Gate Neurosciences Collaborates with Beacon Biosignals to Leverage EEG Biomarkers in Major Depressive Disorder. Learn more: ow.ly/CqVz50Qu1vO
Gate Neurosciences retweeted
In this article, Gate Neurosciences details their role on taking on depression with event-driven #pharmacology.
They also discuss he challenges & promise of NMDA receptor #modulation, the role of EEG #biomarkers in #DrugDevelopment & much more: drugdiscoverytrends.com/gate…
Gate Neurosciences retweeted
I will be in Boston next week at the Cowen Healthcare Conference Mar 6-8. Looking forward to seeing everyone. We are making great progress at Gate Neuro and have news forthcoming about our expanded R&D and results from our clinical biomarker study. #neuroscience #mentalheath
Gate Neurosciences retweeted
The underlying mechanism of ketamine in depression requires downstream NMDAR-activation. New publication from Todd Gould (gouldlab.org/)
jneurosci.org/content/early/…






